Hepatitis B immune globulin

Hepatitis B immune globulin (HBIG) is a sterile solution of immune globulins that is used to provide passive immunity against the hepatitis B virus (HBV). It is used to prevent HBV infection in people who have been exposed to the virus and in those who are at high risk of infection, such as newborns of mothers who are infected with HBV. HBIG may help to reduce the severity and duration of the infection if it is given soon after exposure to the virus. It is usually given in combination with the HBV vaccine.

Hepatitis B immune globulin (HBIG), unlike the vaccine, is not a preventative measure in the traditional sense. Instead, it's a temporary source of antibodies designed to combat an existing or imminent Hepatitis B infection. Here's a detailed explanation:

Function:

  • Composition: HBIG is an injectable preparation derived from the blood plasma of individuals with high levels of antibodies specifically against the Hepatitis B virus (HBV).
  • Mechanism: These antibodies, primarily immunoglobulin G (IgG), act immediately upon injection to neutralize HBV and prevent it from establishing an infection or lessen its severity.

Applications:

  • Post-exposure prophylaxis: HBIG is administered after potential exposure to HBV, such as:
    • Accidental needle stick injuries with HBV-contaminated equipment.
    • Sexual contact with an HBV-positive individual.
    • Birth to a mother infected with HBV.
  • Immunosuppressed individuals: People with weakened immune systems who are unable to mount a proper response to the Hepatitis B vaccine may receive HBIG for added protection.
  • Liver transplant recipients: In some cases, HBIG is used to prevent HBV recurrence after liver transplantation if the donor organ was infected.

Key points to remember:

  • Temporary protection: HBIG offers short-term immunity, lasting only for weeks to a few months.
  • Not a substitute for vaccination: HBIG does not provide long-lasting immunity like the Hepatitis B vaccine. Vaccination remains the primary strategy for preventing chronic HBV infection.
  • Treatment limitations: HBIG is not a cure for Hepatitis B and doesn't work against other viruses.
     
Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J06 Immune sera and immunoglobulins
J06B - Immunoglobulins
J06BB Specific immunoglobulins
External Links